Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization

International Journal of Molecular Sciences
Patrick MaierCarsten Herskind

Abstract

During the last few decades, improvements in the planning and application of radiotherapy in combination with surgery and chemotherapy resulted in increased survival rates of tumor patients. However, the success of radiotherapy is impaired by two reasons: firstly, the radioresistance of tumor cells and, secondly, the radiation-induced damage of normal tissue cells located in the field of ionizing radiation. These limitations demand the development of drugs for either radiosensitization of tumor cells or radioprotection of normal tissue cells. In order to identify potential targets, a detailed understanding of the cellular pathways involved in radiation response is an absolute requirement. This review describes the most important pathways of radioresponse and several key target proteins for radiosensitization.

References

Jul 2, 1992·Nature·D P Lane
Sep 28, 1991·Lancet·C M WestR D Hunter
May 15, 1991·International Journal of Radiation Oncology, Biology, Physics·B EmamiM Wesson
Jan 1, 1988·Free Radical Biology & Medicine·C Richter, B Frei
Dec 1, 1987·The Journal of Antibiotics·I TakahashiH Nakano
Jan 1, 1982·International Journal of Radiation Oncology, Biology, Physics·L J PetersG H Fletcher
Sep 29, 1995·The Journal of Biological Chemistry·J K WestwickD A Brenner
Apr 1, 1993·Toxicology Letters·C Richter, J Schlegel
Jan 12, 1996·The Journal of Biological Chemistry·Y R ChenT H Tan
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·D A AlcortaJ C Barrett
Dec 1, 1996·The Journal of Cell Biology·S M FrischS Sicks
Apr 1, 1997·The EMBO Journal·E Bossy-WetzelM Yaniv
Nov 5, 1997·Nature Genetics·M Kastan
May 2, 1998·The EMBO Journal·C ScaffidiM E Peter
Jul 29, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M VerheijH Bartelink
Feb 18, 1999·Current Opinion in Chemical Biology·E C JonathanW G McKenna
Dec 22, 1999·International Journal of Radiation Biology·A A HillL D Skarsgard
Mar 18, 2000·The Journal of Biological Chemistry·T LinD R Green
Jul 27, 2000·The Journal of Biological Chemistry·V A SmitsR H Medema
Aug 10, 2000·Nature Cell Biology·A SalehE S Alnemri
Sep 12, 2000·Nature Cell Biology·J M BrueyC Garrido
Sep 26, 2000·Molecular and Cellular Biology·S J CharetteJ Landry
Oct 29, 2000·Experimental Gerontology·C Herskind, H P Rodemann
Dec 15, 2000·Cell·K H Vousden
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Mar 27, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M Segal, D J Clarke
Jul 28, 2001·International Journal of Cancer. Journal International Du Cancer·M A Sheard
Sep 7, 2001·Genes & Development·R T Abraham
Oct 16, 2001·Onkologie·F WenzK J Weber
Nov 2, 2001·Nature·T ReyaI L Weissman
Mar 5, 2002·Nature Medicine·Vladimir J N BykovGalina Selivanova
May 7, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·I B RoninsonB D Chang
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams

❮ Previous
Next ❯

Citations

Jun 18, 2016·International Journal of Molecular Sciences·Deguan LiFeiyue Fan
Sep 15, 2016·International Journal of Radiation Biology·Javed MahmoodZeljko Vujaskovic
Jan 25, 2017·Cancer Biotherapy & Radiopharmaceuticals·Rogier LangeAlbert A Geldof
Feb 15, 2017·Biochimica Et Biophysica Acta. Molecular Cell Research·Elke DecrockLuc Leybaert
Jul 12, 2016·International Journal of Molecular Sciences·Jui-Hung WengYu-Liang Kuo
Sep 29, 2017·International Journal of Molecular Sciences·Michael HausmannMichael Blank
Apr 11, 2018·Radiation Research·Katherine D CastleDavid G Kirsch
Sep 4, 2017·Environmental Health : a Global Access Science Source·Janet M GrayJeanne Rizzo
Dec 23, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Hui ChangWei-Wei Xiao
Mar 4, 2018·Nature Communications·C Daniel De Magalhaes FilhoAndrew Dillin
Mar 16, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Selvinaz YakanAhmet Cakir
Jun 14, 2019·Journal of Cellular Biochemistry·Bagher FarhoodAmirhossein Ahmadi
Sep 6, 2019·International Journal of Radiation Biology·Andrew S RileyJohn Greenman
Feb 1, 2018·Therapeutic Advances in Medical Oncology·Thomas WalleFernando Lecanda
Sep 22, 2019·Cells·Wanyeon KimBuHyun Youn
Sep 20, 2019·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·Ali QureishiValentine M Macaulay
Oct 26, 2018·International Journal of Radiation Biology·Tyler A BeachJacob N Finkelstein
Jan 9, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Sara LundstenMarika Nestor
Sep 25, 2017·Oncotarget·Aline Kowalski-ChauvelCatherine Seva
Feb 5, 2019·International Journal of Radiation Biology·Hossein MozdaraniAsghar Aghamohammadi
Aug 18, 2020·Cancer Communications·Mayya Alexandrovna DymovaElena Vladimirovna Kuligina
Sep 13, 2019·Journal of Experimental & Clinical Cancer Research : CR·So-Yeon ParkJeong-Seok Nam
Jun 2, 2018·Current Medicinal Chemistry·Seema Gupta, Bilikere S Dwarakanath
Sep 21, 2017·Oncology Letters·Manu GnanamonyChristopher S Gondi
Nov 6, 2018·Frontiers in Pharmacology·Natalia Pajuelo-LozanoIsabel Sanchez-Perez
Feb 27, 2019·Current Drug Targets·Yucui Zhao, Siyu Chen
Nov 9, 2019·International Journal of Molecular Sciences·Tünde SzatmáriKatalin Lumniczky

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
ubiquitination
xenografts
chromosomal aberrations
xenograft
acetylation

Clinical Trials Mentioned

NCT02293850
NCT01554969
NCT02389751

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Patrick MaierCarsten Herskind
Hematology/oncology Clinics of North America
Phyllis WachsbergerAdam P Dicker
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Marcel VerheijBaukelien van Triest
© 2022 Meta ULC. All rights reserved